Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001238880 | SCV001411713 | pathogenic | Ataxia-telangiectasia syndrome | 2019-10-16 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Cys489Tyrfs*9) in the ATM gene. It is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with ATM-related conditions. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). |